Neurotech International

Neurotech International Dividend

Dividend of Neurotech International (NTI.AX) as of Nov 15, 2026.

Dividend

0.00AUD

Last updated:

How much dividend does Neurotech International 2026 pay?

According to the latest status from November 2026, Neurotech International paid a total of 0.00 AUD per share in dividends within the last 12 months. With the current Neurotech International price of 0.02 AUD, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical Neurotech International Dividends

Historical Neurotech International Dividends
PaydateDividend

The Neurotech International Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2022
0.00 AUD
Jan 1, 2023
0.00 AUD
Jan 1, 2024
0.00 AUD
Jan 1, 2025
0.00 AUD
Jan 1, 2026
0.00 AUD
Jan 1, 2027 (e)
0.00 AUD
Jan 1, 2028 (e)
0.00 AUD
Jan 1, 2029 (e)
0.00 AUD
The Neurotech International Dividend history
YEARDividendYoY
est0.00AUD—
est0.00AUD—
est0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—

Is the Neurotech International Dividend Safe?

Neurotech International has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding Neurotech International's Dividend Distributions

Neurotech International’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Neurotech International's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Neurotech International's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Neurotech International’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Neurotech International Stock analysis

What does Neurotech International do? Neurotech International Ltd. generates revenue through the development and commercialization of medical devices and solutions, primarily targeting pediatric neurological disorders. The company's key product, Mente Autism, is a portable EEG headband that uses closed-loop neurofeedback to assist children with autism spectrum disorder (ASD) by improving relaxation and engagement. Clinical studies assess the neuro-protective and anti-inflammatory effects of its NTI/Dolce cannabis strains, which are part of its development program NTI164 that completed a Phase I/II trial for ASD treatment. The firm focuses on commercializing these neurological solutions for pediatric use in home therapy settings. The company's primary customers are families and healthcare providers managing children with autism spectrum disorder (ASD). Mente Autism is marketed as a home therapy device to increase engagement and reduce anxiety in autistic children with elevated delta-band brain activity. Neurotech International Ltd. leverages its clinical trial results to support the commercialization of Mente Autism and its NTI/Dolce cannabis strains, which are positioned as therapeutic solutions for neurological conditions. The firm's revenue streams are derived from the sale of Mente Autism devices and the potential future commercialization of its NTI/Dolce cannabis-based products. Neurotech International Ltd. operates within the medical device sector, emphasizing pediatric neurological solutions. Its products, including Mente Autism and the NTI/Dolce cannabis strains, are developed through clinical studies to address specific neurological disorders. The company's focus on home-based therapy for ASD patients differentiates its offerings in the market, targeting a niche segment of families seeking non-invasive, accessible treatments for children with autism. Neurotech International is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Neurotech International stock

Neurotech International paid dividends every year for the past 0 years.

Neurotech International is assigned to the 'Health' sector.

The dividends of Neurotech International are distributed in AUD.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

All Key Metrics — Neurotech International